MANAGEMENT OF ENDOCRINE DISEASE: Diagnostic and therapeutic approach of tall stature
Open Access
- 1 June 2017
- journal article
- review article
- Published by Oxford University Press (OUP) in European Journal of Endocrinology
- Vol. 176 (6) , R339-R353
Abstract
Tall stature is defined as a height of more than 2 standard deviations (s.d.) above average for same sex and age. Tall individuals are usually referred to endocrinologists so that hormonal disorders leading to abnormal growth are excluded. However, the majority of these patients have familial tall stature or constitutional advance of growth (generally associated with obesity), both of which are diagnoses of exclusion. It is necessary to have familiarity with a large number of rarer overgrowth syndromes, especially because some of them may have severe complications such as aortic aneurysm, thromboembolism and tumor predisposition and demand-specific follow-up approaches. Additionally, endocrine disorders associated with tall stature have specific treatments and for this reason their recognition is mandatory. With this review, we intend to provide an up-to-date summary of the genetic conditions associated with overgrowth to emphasize a practical diagnostic approach of patients with tall stature and to discuss the limitations of current growth interruption treatment options.Keywords
This publication has 105 references indexed in Scilit:
- Genome-wide association and longitudinal analyses reveal genetic loci linking pubertal height growth, pubertal timing and childhood adiposityHuman Molecular Genetics, 2013
- Effect of obesity on linear growthCurrent Opinion in Endocrinology, Diabetes and Obesity, 2013
- Patterns of linear growth and skeletal maturation from birth to 18 years of age in overweight young adultsInternational Journal of Obesity, 2011
- Growing into obesity: Patterns of height growth in those who become normal weight, overweight, or obese as young adultsAmerican Journal of Human Biology, 2011
- Auxology: An UpdateHormone Research in Paediatrics, 2010
- A review of trisomy X (47,XXX)Orphanet Journal of Rare Diseases, 2010
- Consensus Statement: Chromosomal Microarray Is a First-Tier Clinical Diagnostic Test for Individuals with Developmental Disabilities or Congenital AnomaliesThe American Journal of Human Genetics, 2010
- Triple X syndrome: a review of the literatureEuropean Journal of Human Genetics, 2009
- Isotretinoin effects on boneJournal of the American Academy of Dermatology, 2001
- Premature epiphyseal closure—a complication of etretinate therapy in childrenJournal of the American Academy of Dermatology, 1986